About us
Purpose Pharma is a European based pharmaceutical company focusing on the development and commercialization of innovative rare disease and specialty care products in areas of high unmet medical need.
Recent news
Stockholm, November 17, 2025 – Purpose Pharma International AB today announced that ATTROGY® (diflunisal) is now available in Germany for the treatment of hereditary transthyretin-mediated (hATTR or ATTRv) amyloidosis in adult patients
Stockholm, July 31, 2025 – Purpose Pharma International AB today announced that the European Commission (EC) has granted ATTROGY® (diflunisal) marketing authorization for the treatment of hereditary transthyretin-mediated (hATTR or
Stockholm, April 28, 2025 – Purpose Pharma International AB today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a
People
Purpose
Products
Purpose
Our purpose is to help people with rare diseases live a better life. Through our own products and by supplying the healthcare system with unlicensed medicines, we provide treatments that make a change with the aim to improve the lives of patients and their families.
What we do
We invest in the development of products to help people with rare diseases live a better life.
